Silexion Therapeutics Corp (SLXN) concluded trading on Thursday at a closing price of $2.42, with 6.01 million shares of worth about $14.55 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -97.58% during that period and on December 19, 2024 the price saw a gain of about 13.08%. Currently the company’s common shares owned by public are about 1.24M shares, out of which, 1.02M shares are available for trading.
Stock saw a price change of -27.54% in past 5 days and over the past one month there was a price change of 18.87%. Year-to-date (YTD), SLXN shares are showing a performance of -97.52% which decreased to -97.32% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.86 but also hit the highest price of $122.02 during that period. The average intraday trading volume for Silexion Therapeutics Corp shares is 808.12K. The stock is currently trading -16.16% below its 20-day simple moving average (SMA20), while that difference is down -10.94% for SMA50 and it goes to -95.83% lower than SMA200.
Silexion Therapeutics Corp (NASDAQ: SLXN) currently have 1.24M outstanding shares and institutions hold larger chunk of about 8.09% of that.
The stock has a current market capitalization of $3.88M and its 3Y-monthly beta is at 0.01. It has posted earnings per share of -$19.71 in the same period. It has Quick Ratio of 0.85. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SLXN, volatility over the week remained 28.29% while standing at 24.56% over the month.
